Skip to main content
C.Q. Pharmaceutical Holding Co., Ltd. logo

C.Q. Pharmaceutical Holding Co., Ltd. — Investor Relations & Filings

Ticker · 000950 ISIN · CNE0000010K0 Shenzhen Stock Exchange Wholesale and retail trade
Open in API
Filings indexed 2,883 across all filing types
Latest filing 2023-04-26 AGM Information
Country CN China
Listing Shenzhen Stock Exchange 000950

About C.Q. Pharmaceutical Holding Co., Ltd.

https://www.cqphar.com

C.Q. Pharmaceutical Holding Co., Ltd. is a comprehensive pharmaceutical enterprise specializing in the distribution, retail, and supply chain management of healthcare products. The company operates an extensive network focused on the wholesale of pharmaceuticals and medical devices, providing integrated logistics and warehousing solutions to healthcare providers and manufacturers. Its core business activities encompass the procurement and distribution of a wide range of prescription drugs, over-the-counter medications, and specialized medical equipment. Through its retail pharmacy operations and third-party logistics services, the company facilitates the efficient delivery of medical supplies. C.Q. Pharmaceutical Holding Co., Ltd. emphasizes technological integration within its supply chain to optimize inventory management and ensure the integrity of healthcare products throughout the distribution lifecycle.

Recent filings

Filing Released Lang Actions
年度股东大会通知
AGM Information Classification · 95% confidence The document is a detailed notice about the convening of the 2022 Annual General Meeting (AGM) of the company 重药控股股份有限公司. It includes information about the meeting date, voting procedures, agenda items, and proxy forms. The document does not contain financial statements or detailed financial analysis but rather logistical and procedural information related to the AGM. It also references the 2022 annual report and other reports to be voted on but does not include the reports themselves. The document length is 4422 characters, which is relatively short and consistent with a meeting notice rather than a full report. Therefore, this document fits the category of AGM Information (AGM-R).
2023-04-26 Chinese
内部控制自我评价报告
Audit Report / Information Classification · 95% confidence The document is titled '2022 年度内部控制评价报告' which translates to '2022 Annual Internal Control Evaluation Report'. It discusses the evaluation of the company's internal control effectiveness as of December 31, 2022, including financial and non-financial internal control defects, their classification, and remediation status. The document is a detailed report on internal control evaluation, which is a type of audit-related report but not a full annual report (10-K). It is not a brief announcement or a certification letter but a substantive report on internal control evaluation. This fits best under the category of Audit Report / Information (AR), which includes standalone audit reports and applied accounting principles. The document length is 4463 characters, which is substantive enough to be a report rather than a mere announcement. Therefore, the classification is AR with high confidence. FY 2022
2023-04-26 Chinese
2022年度财务决算报告
Annual Report Classification · 95% confidence The document is titled as the 2022 annual financial settlement report of 重药控股股份有限公司, containing detailed financial statements such as balance sheet, income statement, and cash flow statement for the full fiscal year ending December 31, 2022. It includes audited financial data with a standard unqualified audit opinion from an accounting firm. The content covers comprehensive financial performance, asset and liability details, profit and loss analysis, and cash flow changes for the entire year 2022. The document length is 3660 characters, which is relatively short but contains substantive financial data and analysis, not just an announcement or certification. Therefore, it is a full Annual Report (10-K equivalent) rather than a report publication announcement or regulatory filing. Hence, the correct classification is Annual Report (10-K). FY 2022
2023-04-26 Chinese
2022年年度报告摘要
Annual Report Classification · 100% confidence The document is titled as the "2022 Annual Report Summary" of Chongqing Pharmaceutical Holdings Co., Ltd. It contains detailed financial data for the full fiscal year 2022, including total assets, net profit, revenue breakdowns by business segment and product category, shareholder information, bond issuance details, and business operations analysis. The document is comprehensive and covers the company's full-year financial performance and business overview, which aligns with the characteristics of an Annual Report (10-K). It is not a brief announcement or a presentation, nor is it a partial or quarterly report. Therefore, the document is classified as an Annual Report (10-K). FY 2022
2023-04-26 Chinese
关于聘任公司总经理的公告
Board/Management Information Classification · 100% confidence The document is an announcement regarding the appointment and dismissal of senior management positions, specifically the general manager and deputy general manager of the company. It includes details about the board meeting decision, the new appointee's resume, and compliance with relevant laws and regulations. There is no financial data, earnings information, or report publication mentioned. This fits the category of Board/Management Information (MANG), which covers announcements of changes in the company's board of directors or senior management.
2023-04-26 Chinese
关于2022年度利润分配预案公告
Notice of Dividend Amount Classification · 95% confidence The document is an announcement regarding the 2022 annual profit distribution plan of the company. It includes details about the dividend payout per share, approval by the board of directors, supervisory board, and independent directors, and mentions that the plan will be submitted to the shareholders' meeting for approval. The document does not contain full financial statements or comprehensive financial performance data but focuses on the dividend distribution proposal and related approvals. It is a typical announcement of dividend amount and payment details rather than a full annual report or earnings release. Therefore, the appropriate classification is Notice of Dividend Amount (DIV). The document length is short (1638 characters), consistent with an announcement rather than a full report.
2023-04-26 Chinese

Browse filings by year

27 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.